NK cell development, homeostasis and function: Parallels with CD8 + T cells

Nature Reviews Immunology

Volumn 11, Issue 10, 2011, Pages 645-657

  Sun, Joseph C ^a   Lanier, Lewis L ^b  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BASIC LEUCINE ZIPPER TRANSCRIPTION FACTOR; BASIC LEUCINE ZIPPER TRANSCRIPTION FACTOR E4BP4; INTERLEUKIN 15; UNCLASSIFIED DRUG;

ANTIGEN SPECIFICITY; CD8+ T LYMPHOCYTE; CELL DIFFERENTIATION; CELL FUNCTION; CELL LINEAGE; CELL MATURATION; CELL MIGRATION; CELL PROLIFERATION; CELL SURVIVAL; CELLULAR DISTRIBUTION; CELLULAR IMMUNITY; HOMEOSTASIS; HUMAN; LYMPHOCYTOPENIA; MEMORY CELL; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; REVIEW; T LYMPHOCYTE ACTIVATION; VIRUS INFECTION;

ANIMALS; CD8-POSITIVE T-LYMPHOCYTES; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL SURVIVAL; CYTOKINES; DNA VIRUS INFECTIONS; HOMEOSTASIS; HUMANS; IMMUNOLOGIC MEMORY; KILLER CELLS, NATURAL; LYMPHOCYTE ACTIVATION; MAJOR HISTOCOMPATIBILITY COMPLEX; MICE; MICE, TRANSGENIC; RECEPTORS, ANTIGEN, T-CELL; RECEPTORS, CYTOKINE; RNA VIRUS INFECTIONS; TRANSCRIPTION FACTORS;

EID: 80053133221     PISSN: 14741733     EISSN: 14741741     Source Type: Journal    
DOI: 10.1038/nri3044     Document Type: Review

References (182)

1. Sun, J. C. & Lanier, L. L. in The Immune Response to Infection (eds Kaufmann, S., Rouse, B. & Sacks, D.) 197-207 (ASM Press, Washington DC, 2010).
2. Sun, J. C., Lopez-Verges, S., Kim, C. C., DeRisi, J. L. & Lanier, L. L. NK cells and immune "memory". J. Immunol. 186, 1891-1897 (2011).
3. Vivier, E. et al. Innate or adaptive immunity? The example of natural killer cells. Science 331, 44-49 (2011).
4. Di Santo, J. P. Natural killer cell developmental pathways: a question of balance. Annu. Rev. Immunol. 24, 257-286 (2006).
5. Yokoyama, W. M., Kim, S. & French, A. R. The dynamic life of natural killer cells. Annu. Rev. Immunol. 22, 405-429 (2004). (Pubitemid 38680428)
6. Borghesi, L. et al. B lineage-specific regulation of V(D)J recombinase activity is established in common lymphoid progenitors. J. Exp. Med. 199, 491-502 (2004). (Pubitemid 38233833)
7. Igarashi, H., Gregory, S. C., Yokota, T., Sakaguchi, N. & Kincade, P. W. Transcription from the RAG1 locus marks the earliest lymphocyte progenitors in bone marrow. Immunity 17, 117-130 (2002). (Pubitemid 35245955)
8. Kouro, T., Kumar, V. & Kincade, P. W. Relationships between early B-and NK-lineage lymphocyte precursors in bone marrow. Blood 100, 3672-3680 (2002). (Pubitemid 35303938)
9. Pilbeam, K. et al. The ontogeny and fate of NK cells marked by permanent DNA rearrangements. J. Immunol. 180, 1432-1441 (2008).
10. Yokota, T. et al. Unique properties of fetal lymphoid progenitors identified according to RAG1 gene expression. Immunity 19, 365-375 (2003). (Pubitemid 37153413)
11. Mombaerts, P. et al. RAG-1-deficient mice have no mature B and T lymphocytes. Cell 68, 869-877 (1992).
12. Shinkai, Y. et al. RAG-2-deficient mice lack mature lymphocytes owing to inability to initiate V(D)J rearrangement. Cell 68, 855-867 (1992).
13. Kumar, V., Ben-Ezra, J., Bennett, M. & Sonnenfeld, G. Natural killer cells in mice treated with 89strontium: normal target-binding cell numbers but inability to kill even after interferon administration. J. Immunol. 123, 1832-1838 (1979). (Pubitemid 10229573)
14. Seaman, W. E. et al. β-Estradiol reduces natural killer cells in mice. J. Immunol. 121, 2193-2198 (1978). (Pubitemid 9075182)
15. Herberman, R. B., Nunn, M. E., Holden, H. T. & Lavrin, D. H. Natural cytotoxic reactivity of mouse lymphoid cells against syngeneic and allogeneic tumors. II. Characterization of effector cells. Int. J. Cancer 16, 230-239 (1975).
16. Kiessling, R., Klein, E., Pross, H. & Wigzell, H. "Natural" killer cells in the mouse. II. Cytotoxic cells with specificity for mouse Moloney leukemia cells. Characteristics of the killer cell. Eur. J. Immunol. 5, 117-121 (1975).
17. Su, H. C., Ishikawa, R. & Biron, C. A. Transforming growth factor-β expression and natural killer cell responses during virus infection of normal, nude, and SCID mice. J. Immunol. 151, 4874-4890 (1993).
18. Vosshenrich, C. A. et al. A thymic pathway of mouse natural killer cell development characterized by expression of GATA-3 and CD127. Nature Immunol. 7, 1217-1224 (2006). (Pubitemid 44594318)
19. Freud, A. G. et al. A human CD34+ subset resides in lymph nodes and differentiates into CD56bright natural killer cells. Immunity 22, 295-304 (2005). (Pubitemid 40387472)
20. Andrews, D. M. & Smyth, M. J. A potential role for RAG-1 in NK cell development revealed by analysis of NK cells during ontogeny. Immunol. Cell Biol. 88, 107-116 (2010).
21. Kim, S. et al. In vivo developmental stages in murine natural killer cell maturation. Nature Immunol. 3, 523-528 (2002). (Pubitemid 34662303)
22. Lehar, S. M., Dooley, J., Farr, A. G. & Bevan, M. J. Notch ligands Delta1 and Jagged1 transmit distinct signals to T-cell precursors. Blood 105, 1440-1447 (2005). (Pubitemid 40223659)
23. Schmitt, T. M. & Zρiga-Pflcker, J. C. Induction of T cell development from hematopoietic progenitor cells by Delta-like-1 in vitro. Immunity 17, 749-756 (2002). (Pubitemid 35477794)
24. Williams, N. S. et al. Differentiation of NK1.1+, Ly49+ NK cells from Flt3+ multipotent marrow progenitor cells. J. Immunol. 163, 2648-2656 (1999). (Pubitemid 29399189)
25. Ma, A., Koka, R. & Burkett, P. Diverse functions of IL-2, IL-15, and IL-7 in lymphoid homeostasis. Annu. Rev. Immunol. 24, 657-679 (2006).
26. Kennedy, M. K. et al. Reversible defects in natural killer and memory CD8 T cell lineages in interleukin 15-deficient mice. J. Exp. Med. 191, 771-780 (2000).
27. Lodolce, J. P. et al. IL-15 receptor maintains lymphoid homeostasis by supporting lymphocyte homing and proliferation. Immunity 9, 669-676 (1998). (Pubitemid 28557595)
28. Kondo, M., Weissman, I. L. & Akashi, K. Identification of clonogenic common lymphoid progenitors in mouse bone marrow. Cell 91, 661-672 (1997). (Pubitemid 27513657)
29. Karre, K., Ljunggren, H. G., Piontek, G. & Kiessling, R. Selective rejection of H-2-deficient lymphoma variants suggests alternative immune defence strategy. Nature 319, 675-678 (1986). (Pubitemid 16119452)
30. Ljunggren, H. G. & Karre, K. In search of the 'missing self': MHC molecules and NK cell recognition. Immunol. Today 11, 237-244 (1990). (Pubitemid 20198988)
31. Anfossi, N. et al. Human NK cell education by inhibitory receptors for MHC class I. Immunity 25, 331-342 (2006). (Pubitemid 44224147)
32. Chalifour, A. et al. A role for cis interaction between the inhibitory Ly49A receptor and MHC class I for natural killer cell education. Immunity 30, 337-347 (2009).
33. Fernandez, N. C. et al. A subset of natural killer cells achieves self-tolerance without expressing inhibitory receptors specific for self-MHC molecules. Blood 105, 4416-4423 (2005). (Pubitemid 40720789)
34. Johansson, S. et al. Natural killer cell education in mice with single or multiple major histocompatibility complex class I molecules. J. Exp. Med. 201, 1145-1155 (2005). (Pubitemid 40524682)
35. Kim, S. et al. Licensing of natural killer cells by host major histocompatibility complex class I molecules. Nature 436, 709-713 (2005). (Pubitemid 41117274)
36. Brodin, P., Lakshmikanth, T., Johansson, S., Karre, K. & Hoglund, P. The strength of inhibitory input during education quantitatively tunes the functional responsiveness of individual natural killer cells. Blood 113, 2434-2441 (2009).
37. Joncker, N. T., Fernandez, N. C., Treiner, E., Vivier, E. & Raulet, D. H. NK cell responsiveness is tuned commensurate with the number of inhibitory receptors for self-MHC class I: the rheostat model. J. Immunol. 182, 4572-4580 (2009).
38. Yu, J. et al. Hierarchy of the human natural killer cell response is determined by class and quantity of inhibitory receptors for self-HLA-B and HLA-C ligands. J. Immunol. 179, 5977-5989 (2007).
39. Lanier, L. L. Up on the tightrope: natural killer cell activation and inhibition. Nature Immunol. 9, 495-502 (2008). (Pubitemid 351560518)
40. Sun, J. C. & Lanier, L. L. Cutting edge: viral infection breaks NK cell tolerance to "missing self". J. Immunol. 181, 7453-7457 (2008).
41. Yokoyama, W. M. & Kim, S. Licensing of natural killer cells by self-major histocompatibility complex class I. Immunol. Rev. 214, 143-154 (2006). (Pubitemid 44707908)
42. Hsu, K. C. et al. Improved outcome in HLA-identical sibling hematopoietic stem-cell transplantation for acute myelogenous leukemia predicted by KIR and HLA genotypes. Blood 105, 4878-4884 (2005). (Pubitemid 40807317)
43. Miller, J. S. et al. Missing KIR ligands are associated with less relapse and increased graft-versus-host disease (GVHD) following unrelated donor allogeneic HCT. Blood 109, 5058-5061 (2007). (Pubitemid 46827806)
44. Orr, M., Murphy, W. & Lanier, L. L. "Unlicensed" natural killer cells dominate the response to cytomegalovirus infection. Nature Immunol. 11, 321-327 (2010).
45. Elliott, J. M., Wahle, J. A. & Yokoyama, W. M. MHC class I-deficient natural killer cells acquire a licensed phenotype after transfer into an MHC class I-sufficient environment. J. Exp. Med. 207, 2073-2079 (2010).
46. Joncker, N. T., Shifrin, N., Delebecque, F. & Raulet, D. H. Mature natural killer cells reset their responsiveness when exposed to an altered MHC environment. J. Exp. Med. 207, 2065-2072 (2010).
47. Lanier, L. L. NK cell recognition. Annu. Rev. Immunol. 23, 225-274 (2005). (Pubitemid 40563170)
48. Abeyweera, T. P., Merino, E. & Huse, M. Inhibitory signaling blocks activating receptor clustering and induces cytoskeletal retraction in natural killer cells. J. Cell Biol. 192, 675-690 (2011).
49. Ogasawara, K., Benjamin, J., Takaki, R., Phillips, J. H. & Lanier, L. L. Function of NKG2D in natural killer cell-mediated rejection of mouse bone marrow grafts. Nature Immunol. 6, 938-945 (2005). (Pubitemid 43090449)
50. Oppenheim, D. E. et al. Sustained localized expression of ligand for the activating NKG2D receptor impairs natural cytotoxicity in vivo and reduces tumor immunosurveillance. Nature Immunol. 6, 928-937 (2005). (Pubitemid 43090448)
51. Sun, J. C. & Lanier, L. L. Tolerance of NK cells encountering their viral ligand during development. J. Exp. Med. 205, 1819-1828 (2008).
52. Tripathy, S. K. et al. Continuous engagement of a self-specific activation receptor induces NK cell tolerance. J. Exp. Med. 205, 1829-1841 (2008).
53. Busslinger, M. Transcriptional control of early B cell development. Annu. Rev. Immunol. 22, 55-79 (2004). (Pubitemid 38680418)
54. Collins, A., Littman, D. R. & Taniuchi, I. RUNX proteins in transcription factor networks that regulate T-cell lineage choice. Nature Rev. Immunol. 9, 106-115 (2009).
55. Maillard, I., Fang, T. & Pear, W. S. Regulation of lymphoid development, differentiation, and function by the Notch pathway. Annu. Rev. Immunol. 23, 945-974 (2005). (Pubitemid 40563190)
56. Bosselut, R. CD4/CD8-lineage differentiation in the thymus: from nuclear effectors to membrane signals. Nature Rev. Immunol. 4, 529-540 (2004). (Pubitemid 38931768)
57. Glimcher, L. H., Townsend, M. J., Sullivan, B. M. & Lord, G. M. Recent developments in the transcriptional regulation of cytolytic effector cells. Nature Rev. Immunol. 4, 900-911 (2004). (Pubitemid 39490765)
58. O'Shea, J. J. & Paul, W. E. Mechanisms underlying lineage commitment and plasticity of helper CD4+ T cells. Science 327, 1098-1102 (2010).
59. Hesslein, D. G. & Lanier, L. L. Transcriptional control of natural killer cell development and function. Adv. Immunol. 109, 45-85 (2011).
60. Ramirez, K. & Kee, B. L. Multiple hats for natural killers. Curr. Opin. Immunol. 22, 193-198 (2010).
61. Aliahmad, P., de la Torre, B. & Kaye, J. Shared dependence on the DNA-binding factor TOX for the development of lymphoid tissue-inducer cell and NK cell lineages. Nature Immunol. 11, 945-952 (2010).
62. Carotta, S., Pang, S. H., Nutt, S. L. & Belz, G. T. Identification of the earliest NK-cell precursor in the mouse BM. Blood 117, 5449-5452 (2011).
63. Duncan, G. S., Mittrucker, H. W., Kagi, D., Matsuyama, T. & Mak, T. W. The transcription factor interferon regulatory factor-1 is essential for natural killer cell function in vivo. J. Exp. Med. 184, 2043-2048 (1996). (Pubitemid 26404496)
64. Intlekofer, A. M. et al. Effector and memory CD8+ T cell fate coupled by T-bet and eomesodermin. Nature Immunol. 6, 1236-1244 (2005). (Pubitemid 43045635)
65. Samson, S. I. et al. GATA-3 promotes maturation, IFN-γ production, and liver-specific homing of NK cells. Immunity 19, 701-711 (2003). (Pubitemid 37490795)
66. Szabo, S. J. et al. A novel transcription factor, T-bet, directs Th1 lineage commitment. Cell 100, 655-669 (2000).
67. Ogasawara, K. et al. Requirement for IRF-1 in the microenvironment supporting development of natural killer cells. Nature 391, 700-703 (1998). (Pubitemid 28113217)
68. Ikawa, T. et al. An essential developmental checkpoint for production of the T cell lineage. Science 329, 93-96 (2010).
69. Kastner, P. et al. Bcl11b represses a mature T-cell gene expression program in immature CD4+CD8+ thymocytes. Eur. J. Immunol. 40, 2143-2154 (2010).
70. Li, L., Leid, M. & Rothenberg, E. V. An early T cell lineage commitment checkpoint dependent on the transcription factor Bcl11b. Science 329, 89-93 (2010).
71. Li, P. et al. Reprogramming of T cells to natural killer-like cells upon Bcl11b deletion. Science 329, 85-89 (2010).
72. Gascoyne, D. M. et al. The basic leucine zipper transcription factor E4BP4 is essential for natural killer cell development. Nature Immunol. 10, 1118-1124 (2009).
73. Kamizono, S. et al. Nfil3/E4bp4 is required for the development and maturation of NK cells in vivo. J. Exp. Med. 206, 2977-2986 (2009).
74. Kashiwada, M. et al. IL-4-induced transcription factor NFIL3/E4BP4 controls IgE class switching. Proc. Natl Acad. Sci. USA 107, 821-826 (2010).
75. Cowell, I. G. E4BP4/NFIL3, a PAR-related bZIP factor with many roles. Bioessays 24, 1023-1029 (2002). (Pubitemid 35326160)
76. Boos, M. D., Yokota, Y., Eberl, G. & Kee, B. L. Mature natural killer cell and lymphoid tissue-inducing cell development requires Id2-mediated suppression of E protein activity. J. Exp. Med. 204, 1119-1130 (2007). (Pubitemid 46798155)
77. Kashiwada, M., Cassel, S. L., Colgan, J. D. & Rothman, P. B. NFIL3/E4BP4 controls type 2 T helper cell cytokine expression. EMBO J. 30, 2071-2082 (2011).
78. Kashiwada, M., Pham, N. L., Pewe, L. L., Harty, J. T. & Rothman, P. B. NFIL3/E4BP4 is a key transcription factor for CD8α+ dendritic cell development. Blood 117, 6193-6197 (2011).
79. Motomura, Y. et al. The transcription factor E4BP4 regulates the production of IL-10 and IL-13 in CD4+ T cells. Nature Immunol. 12, 450-459 (2011).
80. Shi, F. D., Ljunggren, H.-G., La Cava, A. & Van Kaer, L. Organ-specific features of NK cells. Nature Rev. Immunol. 11, 658-671 (2011).
81. Chen, S., Kawashima, H., Lowe, J. B., Lanier, L. L. & Fukuda, M. Suppression of tumor formation in lymph nodes by L-selectin-mediated natural killer cell recruitment. J. Exp. Med. 202, 1679-1689 (2005). (Pubitemid 41815874)
82. Gregoire, C. et al. The trafficking of natural killer cells. Immunol. Rev. 220, 169-182 (2007). (Pubitemid 350045566)
83. Jenne, C. N. et al. T-bet-dependent S1P5 expression in NK cells promotes egress from lymph nodes and bone marrow. J. Exp. Med. 206, 2469-2481 (2009).
84. Walzer, T. et al. Natural killer cell trafficking in vivo requires a dedicated sphingosine 1-phosphate receptor. Nature Immunol. 8, 1337-1344 (2007). (Pubitemid 350131171)
85. Andrews, D. M. et al. NK1.1+ cells and murine cytomegalovirus infection: what happens in situ? J. Immunol. 166, 1796-1802 (2001). (Pubitemid 32114665)
86. Dokun, A. O., Chu, D. T., Yang, L., Bendelac, A. S. & Yokoyama, W. M. Analysis of in situ NK cell responses during viral infection. J. Immunol. 167, 5286-5293 (2001). (Pubitemid 33009767)
87. Bekiaris, V. et al. Ly49H+ NK cells migrate to and protect splenic white pulp stroma from murine cytomegalovirus infection. J. Immunol. 180, 6768-6776 (2008).
88. Salazar-Mather, T. P., Lewis, C. A. & Biron, C. A. Type I interferons regulate inflammatory cell trafficking and macrophage inflammatory protein 1α delivery to the liver. J. Clin. Invest. 110, 321-330 (2002). (Pubitemid 34847964)
89. Tay, C. H. & Welsh, R. M. Distinct organ-dependent mechanisms for the control of murine cytomegalovirus infection by natural killer cells. J. Virol. 71, 267-275 (1997). (Pubitemid 26412288)
90. Fink, P. J. & Hendricks, D. W. Post-thymic maturation: young T cells assert their individuality. Nature Rev. Immunol. 11, 544-549 (2011).
91. Chiossone, L. et al. Maturation of mouse NK cells is a 4-stage developmental program. Blood 113, 5488-5496 (2009).
92. Hayakawa, Y. & Smyth, M. J. CD27 dissects mature NK cells into two subsets with distinct responsiveness and migratory capacity. J. Immunol. 176, 1517-1524 (2006). (Pubitemid 43134295)
93. Huntington, N. D. et al. NK cell maturation and peripheral homeostasis is associated with KLRG1 up-regulation. J. Immunol. 178, 4764-4770 (2007). (Pubitemid 46595257)
94. Takeda, K. et al. TRAIL identifies immature natural killer cells in newborn mice and adult mouse liver. Blood 105, 2082-2089 (2005). (Pubitemid 40731795)
95. Chaix, J. et al. Cutting edge: priming of NK cells by IL-18. J. Immunol. 181, 1627-1631 (2008).
96. Hoshino, K. et al. Cutting edge: generation of IL-18 receptor-deficient mice: evidence for IL-1 receptor-related protein as an essential IL-18 binding receptor. J. Immunol. 162, 5041-5044 (1999). (Pubitemid 29307100)
97. Takeda, K. et al. Defective NK cell activity and Th1 response in IL-18-deficient mice. Immunity 8, 383-390 (1998). (Pubitemid 28188898)
98. Andrews, D. M. et al. Homeostatic defects in interleukin 18-deficient mice contribute to protection against the lethal effects of endotoxin. Immunol. Cell Biol. 25 Jan 2011 (doi:10.1038/icb.2010.168).
99. Reading, P. C. et al. IL-18, but not IL-12, regulates NK cell activity following intranasal herpes simplex virus type 1 infection. J. Immunol. 179, 3214-3221 (2007).
100. Schluns, K. S. & Lefrancois, L. Cytokine control of memory T-cell development and survival. Nature Rev. Immunol. 3, 269-279 (2003). (Pubitemid 37328680)
101. Jamieson, A. M., Isnard, P., Dorfman, J. R., Coles, M. C. & Raulet, D. H. Turnover and proliferation of NK cells in steady state and lymphopenic conditions. J. Immunol. 172, 864-870 (2004). (Pubitemid 38113743)
102. Koka, R. et al. Interleukin (IL)-15Rα-deficient natural killer cells survive in normal but not IL-15Rα-deficient mice. J. Exp. Med. 197, 977-984 (2003). (Pubitemid 36523195)
103. Prlic, M., Blazar, B. R., Farrar, M. A. & Jameson, S. C. In vivo survival and homeostatic proliferation of natural killer cells. J. Exp. Med. 197, 967-976 (2003). (Pubitemid 36523194)
104. Ranson, T. et al. IL-15 is an essential mediator of peripheral NK-cell homeostasis. Blood 101, 4887-4893 (2003). (Pubitemid 36857750)
105. Dubois, S., Mariner, J., Waldmann, T. A. & Tagaya, Y. IL-15Rα recycles and presents IL-15 in trans to neighboring cells. Immunity 17, 537-547 (2002). (Pubitemid 35351500)
106. Lucas, M., Schachterle, W., Oberle, K., Aichele, P. & Diefenbach, A. Dendritic cells prime natural killer cells by trans-presenting interleukin 15. Immunity 26, 503-517 (2007). (Pubitemid 46602996)
107. Mortier, E., Woo, T., Advincula, R., Gozalo, S. & Ma, A. IL-15Rα chaperones IL-15 to stable dendritic cell membrane complexes that activate NK cells via trans presentation. J. Exp. Med. 205, 1213-1225 (2008). (Pubitemid 351679694)
108. Mortier, E. et al. Macrophage-and dendritic-cell-derived interleukin-15 receptor α supports homeostasis of distinct CD8+ T cell subsets. Immunity 31, 811-822 (2009).
109. Castillo, E. F., Stonier, S. W., Frasca, L. & Schluns, K. S. Dendritic cells support the in vivo development and maintenance of NK cells via IL-15 trans-presentation. J. Immunol. 183, 4948-4956 (2009).
110. Stoklasek, T. A., Schluns, K. S. & Lefrancois, L. Combined IL-15/IL-15Rα immunotherapy maximizes IL-15 activity in vivo. J. Immunol. 177, 6072-6080 (2006). (Pubitemid 44628822)
111. Fehniger, T. A. et al. Fatal leukemia in interleukin 15 transgenic mice follows early expansions in natural killer and memory phenotype CD8+ T cells. J. Exp. Med. 193, 219-231 (2001). (Pubitemid 32524453)
112. Cooper, M. A. et al. In vivo evidence for a dependence on interleukin 15 for survival of natural killer cells. Blood 100, 3633-3638 (2002). (Pubitemid 35303933)
113. Huntington, N. D. et al. Interleukin 15-mediated survival of natural killer cells is determined by interactions among Bim, Noxa and Mcl-1. Nature Immunol. 8, 856-863 (2007). (Pubitemid 47103041)
114. Tsunobuchi, H. et al. A protective role of interleukin-15 in a mouse model for systemic infection with herpes simplex virus. Virology 275, 57-66 (2000).
115. Umemura, M., Nishimura, H., Hirose, K., Matsuguchi, T. & Yoshikai, Y. Overexpression of IL-15 in vivo enhances protection against Mycobacterium bovis bacillus Calmette-Guerin infection via augmentation of NK and T cytotoxic 1 responses. J. Immunol. 167, 946-956 (2001). (Pubitemid 32660852)
116. Ferrari-Lacraz, S. et al. Targeting IL-15 receptor-bearing cells with an antagonist mutant IL-15/Fc protein prevents disease development and progression in murine collagen-induced arthritis. J. Immunol. 173, 5818-5826 (2004). (Pubitemid 39392172)
117. Ruchatz, H., Leung, B. P., Wei, X. Q., McInnes, I. B. & Liew, F. Y. Soluble IL-15 receptor α-chain administration prevents murine collagen-induced arthritis: a role for IL-15 in development of antigen-induced immunopathology. J. Immunol. 160, 5654-5660 (1998). (Pubitemid 28267861)
118. Smith, X. G. et al. Selective blockade of IL-15 by soluble IL-15 receptor α-chain enhances cardiac allograft survival. J. Immunol. 165, 3444-3450 (2000).
119. Sun, J. C., Beilke, J. N., Bezman, N. A. & Lanier, L. L. Homeostatic proliferation generates long-lived natural killer cells that respond against viral infection. J. Exp. Med. 208, 357-368 (2011).
120. Cho, B. K., Rao, V. P., Ge, Q., Eisen, H. N. & Chen, J. Homeostasis-stimulated proliferation drives naive T cells to differentiate directly into memory T cells. J. Exp. Med. 192, 549-556 (2000). (Pubitemid 30666255)
121. Goldrath, A. W., Bogatzki, L. Y. & Bevan, M. J. Naive T cells transiently acquire a memory-like phenotype during homeostasis-driven proliferation. J. Exp. Med. 192, 557-564 (2000). (Pubitemid 30666256)
122. Murali-Krishna, K. & Ahmed, R. Cutting edge: naive T cells masquerading as memory cells. J. Immunol. 165, 1733-1737 (2000). (Pubitemid 30643121)
123. Hamilton, S. E., Wolkers, M. C., Schoenberger, S. P. & Jameson, S. C. The generation of protective memory-like CD8+ T cells during homeostatic proliferation requires CD4+ T cells. Nature Immunol. 7, 475-481 (2006).
124. Cheung, K. P., Yang, E. & Goldrath, A. W. Memory-like CD8+ T cells generated during homeostatic proliferation defer to antigen-experienced memory cells. J. Immunol. 183, 3364-3372 (2009).
125. Raulet, D. H. Interplay of natural killer cells and their receptors with the adaptive immune response. Nature Immunol. 5, 996-1002 (2004). (Pubitemid 41057716)
126. Orange, J. S. Human natural killer cell deficiencies. Curr. Opin. Allergy Clin. Immunol. 6, 399-409 (2006). (Pubitemid 44714151)
127. Dokun, A. O. et al. Specific and nonspecific NK cell activation during virus infection. Nature Immunol. 2, 951-956 (2001). (Pubitemid 32976168)
128. Sun, J. C., Beilke, J. N. & Lanier, L. L. Adaptive immune features of natural killer cells. Nature 457, 557-561 (2009).
129. Williams, M. A. & Bevan, M. J. Effector and memory CTL differentiation. Annu. Rev. Immunol. 25, 171-192 (2007). (Pubitemid 46697906)
130. Guma, M. et al. Imprint of human cytomegalovirus infection on the NK cell receptor repertoire. Blood 104, 3664-3671 (2004). (Pubitemid 39564443)
131. Guma, M. et al. Human cytomegalovirus infection is associated with increased proportions of NK cells that express the CD94/NKG2C receptor in aviremic HIV-1-positive patients. J. Infect. Dis. 194, 38-41 (2006).
132. Kuijpers, T. W. et al. Human NK cells can control CMV infection in the absence of T cells. Blood 112, 914-915 (2008).
133. Lopez-Verges, S. et al. Expansion of a unique CD57+NKG2Chi natural killer subset during acute human cytomegalovirus infection. Proc. Natl Acad. Sci. USA 8 Aug 2011 (doi:10.1073/pnas.1110900108).
134. Bjorkstrom, N. K. et al. Rapid expansion and long-term persistence of elevated NK cell numbers in humans infected with hantavirus. J. Exp. Med. 208, 13-21 (2011).
135. Smith-Garvin, J. E., Koretzky, G. A. & Jordan, M. S. T cell activation. Annu. Rev. Immunol. 27, 591-619 (2009).
136. Dorner, B. G. et al. Coordinate expression of cytokines and chemokines by NK cells during murine cytomegalovirus infection. J. Immunol. 172, 3119-3131 (2004). (Pubitemid 38263702)
137. Nandi, D., Gross, J. A. & Allison, J. P. CD28-mediated costimulation is necessary for optimal proliferation of murine NK cells. J. Immunol. 152, 3361-3369 (1994). (Pubitemid 24098032)
138. Andoniou, C. E. et al. Interaction between conventional dendritic cells and natural killer cells is integral to the activation of effective antiviral immunity. Nature Immunol. 6, 1011-1019 (2005). (Pubitemid 41486186)
139. Andrews, D. M., Scalzo, A. A., Yokoyama, W. M., Smyth, M. J. & Degli-Esposti, M. A. Functional interactions between dendritic cells and NK cells during viral infection. Nature Immunol. 4, 175-181 (2003). (Pubitemid 36193020)
140. Krug, A. et al. TLR9-dependent recognition of MCMV by IPC and DC generates coordinated cytokine responses that activate antiviral NK cell function. Immunity 21, 107-119 (2004). (Pubitemid 38925271)
141. Swiecki, M., Gilfillan, S., Vermi, W., Wang, Y. & Colonna, M. Plasmacytoid dendritic cell ablation impacts early interferon responses and antiviral NK and CD8+ T cell accrual. Immunity 33, 955-966 (2010).
142. Sun, J. C., Ma, A. & Lanier, L. L. Cutting edge: IL-15-independent NK cell response to mouse cytomegalovirus infection. J. Immunol. 183, 2911-2914 (2009).
143. Magram, J. et al. IL-12-deficient mice are defective in IFNγ production and type 1 cytokine responses. Immunity 4, 471-481 (1996). (Pubitemid 26354656)
144. Muller, U. et al. Functional role of type I and type II interferons in antiviral defense. Science 264, 1918-1921 (1994). (Pubitemid 24245635)
145. Wu, C., Ferrante, J., Gately, M. K. & Magram, J. Characterization of IL-12 receptor β1 chain (IL-12Rβ1)-deficient mice: IL-12Rβ1 is an essential component of the functional mouse IL-12 receptor. J. Immunol. 159, 1658-1665 (1997). (Pubitemid 127484149)
146. Berg, R. E., Crossley, E., Murray, S. & Forman, J. Memory CD8+ T cells provide innate immune protection against Listeria monocytogenes in the absence of cognate antigen. J. Exp. Med. 198, 1583-1593 (2003). (Pubitemid 37467172)
147. Tough, D. F., Borrow, P. & Sprent, J. Induction of bystander T cell proliferation by viruses and type I interferon in vivo. Science 272, 1947-1950 (1996). (Pubitemid 26234507)
148. Robbins, S. H., Tessmer, M. S., Mikayama, T. & Brossay, L. Expansion and contraction of the NK cell compartment in response to murine cytomegalovirus infection. J. Immunol. 173, 259-266 (2004). (Pubitemid 38797350)
149. Harty, J. T. & Badovinac, V. P. Shaping and reshaping CD8+ T-cell memory. Nature Rev. Immunol. 8, 107-119 (2008). (Pubitemid 351161304)
150. Homann, D., Teyton, L. & Oldstone, M. B. Differential regulation of antiviral T-cell immunity results in stable CD8+ but declining CD4+ T-cell memory. Nature Med. 7, 913-919 (2001). (Pubitemid 32756428)
151. Grayson, J. M., Zajac, A. J., Altman, J. D. & Ahmed, R. Cutting edge: increased expression of Bcl-2 in antigen-specific memory CD8+ T cells. J. Immunol. 164, 3950-3954 (2000). (Pubitemid 30215046)
152. Hildeman, D. A. et al. Activated T cell death in vivo mediated by proapoptotic Bcl-2 family member Bim. Immunity 16, 759-767 (2002). (Pubitemid 34786475)
153. Pellegrini, M., Belz, G., Bouillet, P. & Strasser, A. Shutdown of an acute T cell immune response to viral infection is mediated by the proapoptotic Bcl-2 homology 3-only protein Bim. Proc. Natl Acad. Sci. USA 100, 14175-14180 (2003). (Pubitemid 37499210)
154. Prlic, M. & Bevan, M. J. Exploring regulatory mechanisms of CD8+ T cell contraction. Proc. Natl Acad. Sci. USA 105, 16689-16694 (2008).
155. Wojciechowski, S. et al. Bim/Bcl-2 balance is critical for maintaining naive and memory T cell homeostasis. J. Exp. Med. 204, 1665-1675 (2007). (Pubitemid 47048032)
156. Brady, J., Hayakawa, Y., Smyth, M. J. & Nutt, S. L. IL-21 induces the functional maturation of murine NK cells. J. Immunol. 172, 2048-2058 (2004). (Pubitemid 38182350)
157. Parrish-Novak, J. et al. Interleukin 21 and its receptor are involved in NK cell expansion and regulation of lymphocyte function. Nature 408, 57-63 (2000).
158. Vosshenrich, C. A. et al. Roles for common cytokine receptor γ-chain-dependent cytokines in the generation, differentiation, and maturation of NK cell precursors and peripheral NK cells in vivo. J. Immunol. 174, 1213-1221 (2005).
159. Kasaian, M. T. et al. IL-21 limits NK cell responses and promotes antigen-specific T cell activation: a mediator of the transition from innate to adaptive immunity. Immunity 16, 559-569 (2002). (Pubitemid 34442580)
160. Marrack, P. & Kappler, J. Control of T cell viability. Annu. Rev. Immunol. 22, 765-787 (2004). (Pubitemid 38680441)
161. Sun, J. C., Beilke, J. N. & Lanier, L. L. Immune memory redefined: characterizing the longevity of natural killer cells. Immunol. Rev. 236, 83-94 (2010).
162. Busch, D. H. & Pamer, E. G. T cell affinity maturation by selective expansion during infection. J. Exp. Med. 189, 701-710 (1999).
163. Kiessling, R., Klein, E. & Wigzell, H. "Natural" killer cells in the mouse. I. Cytotoxic cells with specificity for mouse Moloney leukemia cells. Specificity and distribution according to genotype. Eur. J. Immunol. 5, 112-117 (1975).
164. Stetson, D. B. et al. Constitutive cytokine mRNAs mark natural killer (NK) and NK T cells poised for rapid effector function. J. Exp. Med. 198, 1069-1076 (2003). (Pubitemid 37248622)
165. Kaech, S. M. & Wherry, E. J. Heterogeneity and cell-fate decisions in effector and memory CD8+ T cell differentiation during viral infection. Immunity 27, 393-405 (2007). (Pubitemid 47418674)
166. Sallusto, F., Geginat, J. & Lanzavecchia, A. Central memory and effector memory T cell subsets: function, generation, and maintenance. Annu. Rev. Immunol. 22, 745-763 (2004). (Pubitemid 38680440)
167. Sun, J. C. & Lanier, L. L. Natural killer cells remember: an evolutionary bridge between innate and adaptive immunity? Eur. J. Immunol. 39, 2059-2064 (2009).
168. Bevan, M. J. Helping the CD8+ T-cell response. Nature Rev. Immunol. 4, 595-602 (2004).
169. Kaech, S. M. & Ahmed, R. Memory CD8+ T cell differentiation: initial antigen encounter triggers a developmental program in naive cells. Nature Immunol. 2, 415-422 (2001). (Pubitemid 33706139)
170. Mercado, R. et al. Early programming of T cell populations responding to bacterial infection. J. Immunol. 165, 6833-6839 (2000). (Pubitemid 32001151)
171. van Stipdonk, M. J. et al. Dynamic programming of CD8+ T lymphocyte responses. Nature Immunol. 4, 361-365 (2003).
172. Schepers, K. et al. Dissecting T cell lineage relationships by cellular barcoding. J. Exp. Med. 205, 2309-2318 (2008).
173. Schumacher, T. N., Gerlach, C. & van Heijst, J. W. Mapping the life
174. Gill, S., Olson, J. A. & Negrin, R. S. Natural killer cells in allogeneic transplantation: effect on engraftment, graft-versus-tumor, and graft-versus-host responses. Biol. Blood Marrow Transplant. 15, 765-776 (2009).
175. Kurtz, J. & Franz, K. Innate defence: evidence for memory in invertebrate immunity. Nature 425, 37-38 (2003). (Pubitemid 37101708)
176. Cudkowicz, G. & Stimpfling, J. H. Induction of immunity and of unresponsiveness to parental marrow grafts in adult F-1 hybrid mice. Nature 204, 450-453 (1964).
177. Carson, W. E. et al. Interleukin (IL) 15 is a novel cytokine that activates human natural killer cells via components of the IL-2 receptor. J. Exp. Med. 180, 1395-1403 (1994). (Pubitemid 24289613)
178. Gidlund, M., Orn, A., Wigzell, H., Senik, A. & Gresser, I. Enhanced NK cell activity in mice injected with interferon and interferon inducers. Nature 273, 759-761 (1978). (Pubitemid 8357090)
179. Glas, R. et al. Recruitment and activation of natural killer (NK) cells in vivo determined by the target cell phenotype. An adaptive component of NK cell-mediated responses. J. Exp. Med. 191, 129-138 (2000). (Pubitemid 30043654)
180. O'Leary, J. G., Goodarzi, M., Drayton, D. L. & von Andrian, U. H. T cell-and B cell-independent adaptive immunity mediated by natural killer cells. Nature Immunol. 7, 507-516 (2006).
181. Paust, S. et al. Critical role for the chemokine receptor CXCR6 in NK cell-mediated antigen-specific memory of haptens and viruses. Nature Immunol. 11, 1127-1135 (2010).
182. Cooper, M. A. et al. Cytokine-induced memory-like natural killer cells. Proc. Natl Acad. Sci. USA 106, 1915-1919 (2009).